Activating Compound | Comment | Organism | Structure |
---|---|---|---|
dithiothreitol | included in the assay reaction mixture | Enterobacter cloacae |
Application | Comment | Organism |
---|---|---|
medicine | enzyme is a target for the antibiotic fosfomycin | Enterobacter cloacae |
Cloned (Comment) | Organism |
---|---|
expression of wild-type and mutants in Escherichia coli | Enterobacter cloacae |
Protein Variants | Comment | Organism |
---|---|---|
C115S | - |
Enterobacter cloacae |
K22E | site-directed mutagenesis, exchange of conserved Lys residue located near the active site and involved in substrate binding leading to conformational changes, shows less than 0.5% activity compared to the wild-type, altered UDP-GlcNAc binding, highly reduced formation of covalent adduct between active site Cys115 and phosphoenolpyruvate or inhibitor fosfomycin | Enterobacter cloacae |
K22R | site-directed mutagenesis, exchange of conserved Lys residue located near the active site and involved in substrate binding leading to conformational changes, shows less than 0.5% activity compared to the wild-type, slightly reduced formation of covalent adduct between active site Cys115 and phosphoenolpyruvate or inhibitor fosfomycin | Enterobacter cloacae |
K22V | site-directed mutagenesis, exchange of conserved Lys residue located near the active site and involved in substrate binding leading to conformational changes, shows less than 0.5% activity compared to the wild-type, reduced formation of covalent adduct between active site Cys115 and phosphoenolpyruvate or inhibitor fosfomycin | Enterobacter cloacae |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
fosfomycin | - |
Enterobacter cloacae |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Enterobacter cloacae | P33038 | MurA | - |
Enterobacter cloacae DSM 30054 | P33038 | MurA | - |
Purification (Comment) | Organism |
---|---|
recombinant wild-type and mutants from Escherichia coli | Enterobacter cloacae |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
phosphoenolpyruvate + UDP-N-acetyl-alpha-D-glucosamine = phosphate + UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine | Lys22 is located near the active site and involved in substrate binding | Enterobacter cloacae |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
activity of K22 mutants compared to wild-type in forward and reverse reaction, coupled assay | Enterobacter cloacae |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
phosphoenolpyruvate + UDP-N-acetyl-D-glucosamine | substrate binding structure | Enterobacter cloacae | phosphate + UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine | - |
r | |
phosphoenolpyruvate + UDP-N-acetyl-D-glucosamine | thermodynamic parameters of substrate binding, wild-type, C115S and K22 mutants | Enterobacter cloacae | phosphate + UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine | - |
r | |
phosphoenolpyruvate + UDP-N-acetyl-D-glucosamine | substrate binding structure | Enterobacter cloacae DSM 30054 | phosphate + UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine | - |
r | |
phosphoenolpyruvate + UDP-N-acetyl-D-glucosamine | thermodynamic parameters of substrate binding, wild-type, C115S and K22 mutants | Enterobacter cloacae DSM 30054 | phosphate + UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine | - |
r |
Subunits | Comment | Organism |
---|---|---|
More | structure | Enterobacter cloacae |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Enterobacter cloacae |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Enterobacter cloacae |